252 related articles for article (PubMed ID: 7011330)
1. Multivariate analysis of the activity of rifamycins against rapidly growing Mycobacteria, to define an in vitro screening model for their activity against mycobacterium leprae.
Pattyn SR; Hébrant F
Arzneimittelforschung; 1980; 30(12):2099-103. PubMed ID: 7011330
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the bactericidal activity of a series of rifampicins against Mycobacterium leprae.
Pattyn SR
Arzneimittelforschung; 1982; 32(1):15-7. PubMed ID: 7037013
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of a new rifamycin derivative against Mycobacterium leprae.
Dhople AM; Dimova V
Arzneimittelforschung; 1996 Feb; 46(2):210-2. PubMed ID: 8720317
[TBL] [Abstract][Full Text] [Related]
4. Comparative in vitro activities of rifamycin analogues against Mycobacterium leprae.
Dhople AM
Indian J Lepr; 1997; 69(4):377-84. PubMed ID: 9474513
[TBL] [Abstract][Full Text] [Related]
5. Antimycobacterial activities of two newer ansamycins, R-76-1 and DL 473.
Ji BH; Chen JK; Lu XZ; Wang SY; Ni GX; Hou YH; Zhou DH; Tang QK
Int J Lepr Other Mycobact Dis; 1986 Dec; 54(4):563-77. PubMed ID: 3546547
[TBL] [Abstract][Full Text] [Related]
6. In vitro synergistic activity between ofloxacin and ansamycins against Mycobacterium leprae.
Dhople AM; Ibanez MA; Gardner GD
Arzneimittelforschung; 1993 Mar; 43(3):384-6. PubMed ID: 8387790
[TBL] [Abstract][Full Text] [Related]
7. The activity of rifabutin against Mycobacterium leprae.
Yoder LJ; Jacobson RR; Hastings RC
Lepr Rev; 1991 Sep; 62(3):280-7. PubMed ID: 1665534
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antileprosy activity of some dialkyldithiocarbamates.
Makarov V; Riabova OB; Yuschenko A; Urlyapova N; Daudova A; Zipfel PF; Möllmann U
J Antimicrob Chemother; 2006 Jun; 57(6):1134-8. PubMed ID: 16595643
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of extracts and constituents of Pelagonium against rapidly growing mycobacteria.
Seidel V; Taylor PW
Int J Antimicrob Agents; 2004 Jun; 23(6):613-9. PubMed ID: 15194133
[TBL] [Abstract][Full Text] [Related]
10. Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin.
Walker LL; Van Landingham RM; Shinnick TM
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):59-65. PubMed ID: 8326182
[TBL] [Abstract][Full Text] [Related]
11. The activity of several newer antimicrobials against logarithmically multiplying M. leprae in mice.
Burgos J; de la Cruz E; Paredes R; Andaya CR; Gelber RH
Lepr Rev; 2011 Sep; 82(3):253-8. PubMed ID: 22125933
[TBL] [Abstract][Full Text] [Related]
12. Activity of the combination of isoniazid, protionamide and dapsone against Mycobacterium leprae and some other mycobacteria.
Pattyn SR; Portaels F; Van Loo G; Van den Breen L
Arzneimittelforschung; 1981; 31(12):2155-7. PubMed ID: 7037011
[TBL] [Abstract][Full Text] [Related]
13. Use of pyridine for differentiating Mycobacterium leprae from other mycobacteria in direct microscopy.
Slosarek M; Sula L; Theophilus S; Hruby L
Int J Lepr Other Mycobact Dis; 1978; 46(2):154-9. PubMed ID: 355157
[TBL] [Abstract][Full Text] [Related]
14. In vivo activities of novel benzoxazinorifamycins against Mycobacterium leprae.
Dhople AM; Ibanez MA
Indian J Lepr; 1995; 67(4):375-82. PubMed ID: 8849914
[TBL] [Abstract][Full Text] [Related]
15. Antimycobacterial activity of 2-acetylpyridine thiosemicarbazones in relation to their antileprosy activity.
Morrison NE; Collins FM
Int J Lepr Other Mycobact Dis; 1981 Jun; 49(2):180-6. PubMed ID: 7196888
[TBL] [Abstract][Full Text] [Related]
16. An in vitro culture method for screening new drugs against Mycobacterium leprae.
Dhople AM; Ortega I
Indian J Lepr; 1990; 62(1):66-75. PubMed ID: 2193063
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of methods for isolation of DNA from slowly and rapidly growing mycobacteria.
Zhang ZQ; Ishaque M
Int J Lepr Other Mycobact Dis; 1997 Dec; 65(4):469-76. PubMed ID: 9465157
[TBL] [Abstract][Full Text] [Related]
18. The susceptibility testing of 13 strains of Mycobacterium leprae to rifampicin and the determination of minimal effective dosage.
Wang HY; Li WZ; Ye GY; Yu LC; Shi MQ
Lepr Rev; 1991 Sep; 62(3):276-9. PubMed ID: 1795586
[TBL] [Abstract][Full Text] [Related]
19. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria.
Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ
Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064
[TBL] [Abstract][Full Text] [Related]
20. In vitro activities of aminoglycosides, lincosamides, and rifamycins against Mycobacterium leprae.
Franzblau SG
Antimicrob Agents Chemother; 1991 Jun; 35(6):1232-4. PubMed ID: 1929269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
